[Form 3] ASCENTAGE PHARMA GROUP INTERNATIONAL Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

ASCENTAGE PHARMA GROUP INTERNATIONAL Chairman and CEO Yang Dajun filed an initial Form 3 showing his equity interests in the company. The filing reports direct ownership of 1,097,994 Ordinary Shares, along with direct holdings of options and restricted stock units tied to additional Ordinary Shares.

The derivative positions include options over 143,463 Ordinary Shares and restricted stock units over another 143,463 Ordinary Shares, vesting in four equal increments on each of 11/26/2026, 2027, 2028 and 2029. The options have an exercise price of $8.14 per share, shown in USD based on the grant-date conversion from HKD.

Entities associated with Yang, including the Dajun Yang Dynasty Trust, his spouse, and an entity controlled by his spouse, hold 22,054,131, 312,534 and 14,089,111 Ordinary Shares, respectively. The filing states that Yang disclaims beneficial ownership of these indirect holdings except to the extent of his pecuniary interest.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Yang Dajun

(Last) (First) (Middle)

700 KING FARM BLVD

STE 510

(Street)

ROCKVILLE MARYLAND 20850

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ASCENTAGE PHARMA GROUP INTERNATIONAL [ AAPG ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chairman and CEO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	1,097,994	D
Ordinary Shares	22,054,131	I	See Footnote (1)(1)
Ordinary Shares	312,534	I	See Footnote (2)(2)
Ordinary Shares	14,089,111	I	See Footnote (3)(3)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options	(4)	11/26/2035	Ordinary Shares	143,463	$8.14(5)	D
Options	(4)	11/26/2035	Ordinary Shares	103,364	$8.14	I	See Footnote (6)(6)
Restricted stock units	(7)	(7)	Ordinary Shares	143,463	$0	D
Restricted stock units	(7)	(7)	Ordinary Shares	103,364	$0	I	See footnote (6)(6)

Explanation of Responses:

1. Shares held by Dajun Yang Dynasty Trust, of which the Reporting Person is the investment advisor. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

2. Shares held by Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

3. Shares held by HealthQuest Pharma Limited, an entity controlled by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

4. The stock options vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029.

5. The exercise price for the stock options is in HKD, and the exercise price included in the table represents conversion to USD based on the exchange rate on the date of grant.

6. Securities held by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.

7. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029 and have no expiration date.

Remarks:

	Dajun Yang	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Yang Dajun’s Form 3 for ASCENTAGE PHARMA (AAPG) show?

The Form 3 reports Yang Dajun’s initial ownership in ASCENTAGE PHARMA, including 1,097,994 directly held Ordinary Shares plus options and restricted stock units over additional shares, along with several large indirect holdings through a trust, spouse, and a spouse-controlled entity.

How many ASCENTAGE PHARMA (AAPG) shares does Yang Dajun hold directly?

Yang Dajun directly holds 1,097,994 Ordinary Shares of ASCENTAGE PHARMA. This is separate from his derivative awards and indirect interests through related entities, which are reported with specific disclaimers about beneficial ownership and pecuniary interest.

What stock options are reported for Yang Dajun in ASCENTAGE PHARMA (AAPG)?

The filing lists options over 143,463 Ordinary Shares held directly and 103,364 held indirectly. These options have an $8.14 exercise price, vest in four equal annual installments from November 26, 2026 to 2029, and expire on November 26, 2035.

What restricted stock units (RSUs) does Yang Dajun hold in ASCENTAGE PHARMA (AAPG)?

Yang Dajun has RSUs over 143,463 Ordinary Shares directly and 103,364 indirectly. Each RSU converts into one Ordinary Share upon vesting, with vesting in four equal installments on November 26 of 2026, 2027, 2028 and 2029, and no expiration date.

How are Yang Dajun’s indirect ASCENTAGE PHARMA (AAPG) holdings structured?

Indirect holdings are reported through the Dajun Yang Dynasty Trust, his spouse, and HealthQuest Pharma Limited, an entity controlled by his spouse. These entities collectively hold tens of millions of Ordinary Shares, and Yang disclaims beneficial ownership except for any pecuniary interest.

Does Yang Dajun claim full beneficial ownership of all reported ASCENTAGE PHARMA (AAPG) shares?

No. For shares held by the Dajun Yang Dynasty Trust, his spouse, and HealthQuest Pharma Limited, Yang expressly disclaims beneficial ownership except to the extent of his pecuniary interest, and states that their inclusion should not be deemed an admission of beneficial ownership.